Literature DB >> 20799760

Ketoprofen pharmacokinetics, efficacy, and tolerability in pediatric patients.

Hannu Kokki1.   

Abstract

The NSAID ketoprofen is used widely in the management of inflammatory and musculoskeletal conditions, pain, and fever in children and adults. Pharmacokinetic studies show that drug exposure after a single intravenous dose is similar in children and adults (after dose normalization), and thus similar mg/kg bodyweight dosing may be used in children and adults. Ketoprofen crosses the blood-brain barrier and therefore has the potential to cause central analgesic effects. Ketoprofen has been investigated in children for the treatment of pain and fever, peri- and postoperative pain, and inflammatory pain conditions. The results of four clinical trials in febrile conditions with the oral syrup formulation indicate that ketoprofen is as effective as acetaminophen (paracetamol) and ibuprofen, allowing children to rapidly return to daily activities with improvements in sleep quality and appetite. Studies of ketoprofen in the management of postoperative pain indicate that ketoprofen is a highly effective analgesic when administered perioperatively for a variety of surgical types, by a variety of routes, and whether given preoperatively or postoperatively. For adenoidectomy, intravenous ketoprofen provided superior postoperative analgesic efficacy compared with placebo. Analgesic efficacy was similar with intravenous, intramuscular, or rectal routes of administration, but oral administration just before surgery was inferior to intravenous administration in this setting. In patients undergoing a tonsillectomy, intravenous ketoprofen was superior to intravenous tramadol in terms of the need for postoperative rescue analgesia, but did not remove the need for rescue opioid therapy in these patients. Intravenous ketoprofen had superior postoperative analgesic efficacy to placebo when given as an adjuvant to epidural sufentanil analgesia after major surgery. Oral ketoprofen has shown efficacy in the treatment of juvenile rheumatoid arthritis. Ketoprofen is generally well tolerated in pediatric patients. Most of the adverse events reported are mild and transient, and are similar to those observed with other NSAIDs. Long-term tolerability has not yet been fully established in children, but data from three studies in >900 children indicate that oral ketoprofen is well tolerated when administered for up to 3 weeks after surgery. In conclusion, ketoprofen is effective and well tolerated in children for the control of post-surgical pain and for the control of pain and fever in inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20799760     DOI: 10.2165/11534910-000000000-00000

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  56 in total

Review 1.  Ketoprofen. A survey of current publications.

Authors:  J Fossgreen
Journal:  Scand J Rheumatol Suppl       Date:  1976

2.  Comparison of intravenous and oral ketoprofen for postoperative pain after adenoidectomy in children.

Authors:  H Tuomilehto; H Kokki; K Tuovinen
Journal:  Br J Anaesth       Date:  2000-08       Impact factor: 9.166

Review 3.  Pre-emptive analgesia: evidence, current status and future directions.

Authors:  J Katz
Journal:  Eur J Anaesthesiol Suppl       Date:  1995-05

4.  IV perioperative ketoprofen in small children during adenoidectomy.

Authors:  E Nikanne; H Kokki; K Tuovinen
Journal:  Br J Anaesth       Date:  1997-01       Impact factor: 9.166

5.  The effect of cyclooxygenase-2 inhibitors on spinal fusion.

Authors:  John Long; Stephen Lewis; Timothy Kuklo; Yong Zhu; K Daniel Riew
Journal:  J Bone Joint Surg Am       Date:  2002-10       Impact factor: 5.284

6.  Dose-finding studies of ketoprofen in the management of fever in children: report on two randomized, single-blind, comparator-controlled, single-dose, multicentre, phase II studies.

Authors:  Hannu Kokki; Merja Kokki
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

7.  The feasibility of pain treatment at home after adenoidectomy with ketoprofen tablets in small children.

Authors:  H Kokki; E Nikanne; R Ahonen
Journal:  Paediatr Anaesth       Date:  2000       Impact factor: 2.556

8.  [Effects of various dosage of ketoprofen salt suppositories in acute inflammatory disease in infants (3-36 month old) and children (3-13 year old)].

Authors:  V E Carnelli; V A Mei; R Cera; E Clemente; M Previtali
Journal:  Minerva Pediatr       Date:  1995-05       Impact factor: 1.312

9.  A comparison of intravenous ketoprofen versus pethidine on peri-operative analgesia and post-operative nausea and vomiting in paediatric vitreoretinal surgery.

Authors:  R Subramaniam; B Ghai; M Khetarpal; M S Subramanyam
Journal:  J Postgrad Med       Date:  2003 Apr-Jun       Impact factor: 1.476

10.  Measurement of pain in children with self-reporting and behavioral assessment.

Authors:  E L Maunuksela; K T Olkkola; R Korpela
Journal:  Clin Pharmacol Ther       Date:  1987-08       Impact factor: 6.875

View more
  11 in total

Review 1.  Postoperative pain management in children and infants: an update.

Authors:  Christopher Brasher; Benjamin Gafsous; Sophie Dugue; Anne Thiollier; Joelle Kinderf; Yves Nivoche; Robert Grace; Souhayl Dahmani
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.022

2.  Intermittent Hypoxia-Induced Spinal Inflammation Impairs Respiratory Motor Plasticity by a Spinal p38 MAP Kinase-Dependent Mechanism.

Authors:  Adrianne G Huxtable; Stephanie M C Smith; Timothy J Peterson; Jyoti J Watters; Gordon S Mitchell
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

3.  Cyclooxygenase enzyme activity does not impair respiratory motor plasticity after one night of intermittent hypoxia.

Authors:  Adrianne G Huxtable; Elizabeth Kopp; Brendan J Dougherty; Jyoti J Watters; Gordon S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2017-12-09       Impact factor: 1.931

Review 4.  Beta-adrenergic antagonists during general anesthesia reduced postoperative pain: a systematic review and a meta-analysis of randomized controlled trials.

Authors:  Lasse Härkänen; Jari Halonen; Tuomas Selander; Hannu Kokki
Journal:  J Anesth       Date:  2015-07-10       Impact factor: 2.078

5.  The Anti-Inflammation and Anti-Nociception Effect of Ketoprofen in Rats Could Be Strengthened Through Co-Delivery of a H2S Donor, S-Propargyl-Cysteine.

Authors:  Yue Yu; Qinyan Yang; Zhou Wang; Qian Ding; Meng Li; Yudong Fang; Qida He; Yi Zhun Zhu
Journal:  J Inflamm Res       Date:  2021-11-09

Review 6.  Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.

Authors:  Victoria C Ziesenitz; Tatjana Welzel; Madelé van Dyk; Patrick Saur; Matthias Gorenflo; Johannes N van den Anker
Journal:  Paediatr Drugs       Date:  2022-09-02       Impact factor: 3.930

7.  Considerations for a Pediatric Biopharmaceutics Classification System (BCS): application to five drugs.

Authors:  Shivani V Gandhi; William Rodriguez; Mansoor Khan; James E Polli
Journal:  AAPS PharmSciTech       Date:  2014-02-21       Impact factor: 3.246

Review 8.  Laparoscopic surgery: a narrative review of pharmacotherapy in pain management.

Authors:  Sari Sjövall; Merja Kokki; Hannu Kokki
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

9.  A Dose-Finding Study of Dexketoprofen in Patients Undergoing Laparoscopic Cholecystectomy: A Randomized Clinical Trial on Effects on the Analgesic Concentration of Oxycodone.

Authors:  Annika Piirainen; Hannu Kokki; Satu Immonen; Matti Eskelinen; Merja R Häkkinen; Heidi Hautajärvi; Merja Kokki
Journal:  Drugs R D       Date:  2015-12

10.  The safety of ketoprofen in different ages.

Authors:  Claudia Carbone; Pierandrea Rende; Pasquale Comberiati; Domenico Carnovale; Maria Mammì; Giovambattista De Sarro
Journal:  J Pharmacol Pharmacother       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.